Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins?
Authors:
- 1 January 2015
- journal article
- research article
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 97-B (1) , 115-120
Abstract
A poor response to chemotherapy (≤ 90% necrosis) for osteosarcomas leads to poorer survival and an increased risk of local recurrence, particularly if there is a close margin of excision. We evaluated whether amputation confers any survival benefit over limb salvage surgery (LSS) with narrow margins in patients who respond poorly to chemotherapy. We only analysed patients with an osteosarcoma of the limb, a poor response to chemotherapy and close margins on LSS (marginal/intralesional) or primary amputation: 360 patients (36 LSS (intralesional margins), 197 LSS (marginal margins) and 127 amputations) were included. Local recurrence developed in 13 (36%) following LSS with intralesional margins, and 39 (20%) following LSS with marginal margins. There was no local recurrence in patients who underwent amputation. The five-year survival for all patients was 41% (95% confidence interval (CI) 35 to 46), but for those treated by LSS with marginal margins was 46.2% (95% CI 38 to 53), 36.3% (95% CI 27 to 45) for those treated by amputation, and 28% (95 CI 14 to 44) for those treated by LSS with intralesional margins. Patients who had LSS and then developed local recurrence as a first event had the same survival as those who had primary amputation without local recurrence. Prophylactic adjuvant radiotherapy was used in 40 patients but had no discernible effect in preventing local recurrence. Although amputation offered better local control, it conferred no clear survival benefit over LSS with marginal margins in these patients with a poor overall prognosis. Cite this article: Bone Joint J 2015;97-B:115–20.Keywords
This publication has 33 references indexed in Scilit:
- Local Recurrence has only a Small Effect on Survival in High-risk Extremity OsteosarcomaClinical Orthopaedics and Related Research, 2012
- Prognostic factors and outcomes for osteosarcoma: An international collaborationEuropean Journal of Cancer, 2009
- Do pathological fractures influence survival and local recurrence rate in bony sarcomas?European Journal of Cancer, 2007
- Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma IntergroupJNCI: Journal of the National Cancer Institute, 2007
- Management and outcome after local recurrence of osteosarcomaEuropean Journal of Cancer, 2005
- Outcome after local recurrence of osteosarcomaCancer, 2004
- Neoadjuvant Chemotherapy and Local Radiotherapy for High-Grade Osteosarcoma of the ExtremitiesMayo Clinic Proceedings, 2003
- Surgical outcomes in osteosarcomaThe Journal of Bone and Joint Surgery. British volume, 2002
- Osteosarcoma of the limbThe Journal of Bone and Joint Surgery. British volume, 2002
- Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experienceCancer, 1992